{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:23:46Z","timestamp":1789053826486,"version":"build-2803163510"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01876","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T04:46:01Z","timestamp":1597812361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency"],"prefix":"10.3389","volume":"11","author":[{"given":"Aristitsa Mikhailovna","family":"Kostinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelli Kimovna","family":"Akhmatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Alexandrovna","family":"Latysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia Alexeevna","family":"Dagil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana Valentinovna","family":"Klimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Egorovna","family":"Vlasenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina Alexandrovna","family":"Khromova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana Vasilievna","family":"Latysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Petrovich","family":"Kostinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"B1","unstructured":"Global Influenza Strategy 2019\u20132030. World Health Organization2019"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev Vaccin."},{"key":"B3","unstructured":"25771542Recommended Composition of Influenza Virus Vaccines for Use in the 2015\u20132016 Northern Hemisphere Influenza Season2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"Rationale for quadrivalent infuenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/irv.12319","article-title":"Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study","volume":"9","author":"Caini","year":"2015","journal-title":"Influenza Other Respir Viruses."},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.22625\/2072-6732-2017-9-2-17-22","article-title":"The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines","volume":"2","author":"Kharit","year":"2017","journal-title":"J Infektologii."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1016\/j.vaccine.2012.10.025","article-title":"The economic value of a quadrivalent versus trivalent influenza vaccine","volume":"30","author":"Lee","year":"2012","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2334-14-365","article-title":"Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany","volume":"14","author":"Eichner","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines."},{"key":"B11","unstructured":"OraPro-Flu"},{"key":"B12","first-page":"1603","volume-title":"Fundamental Immunology, 6th edition","author":"Paul","year":"2008"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3389\/fimmu.2019.02693","article-title":"Polyoxidonium\u00ae activates cytotoxic lymphocyte responses through dendritic cell maturation: clinical effects in breast cancer","volume":"10","author":"Alexia","year":"2019","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1080\/21645515.2018.1507585","article-title":"Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants","volume":"14","author":"Kostinov","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"B15","unstructured":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clim.2010.03.430","article-title":"Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine","volume":"136","author":"van Assen","year":"2010","journal-title":"Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.vaccine.2016.03.091","article-title":"Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency","volume":"34","author":"Hanitsch","year":"2016","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2011.07.004","article-title":"Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency","volume":"141","author":"van Assen","year":"2011","journal-title":"Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-3083.2011.02561.x","article-title":"Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports","volume":"74","author":"Pedersen","year":"2011","journal-title":"Scand J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.jaci.2018.02.052","article-title":"Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency","volume":"142","author":"Gardulf","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B21","unstructured":"CVID Community Center"},{"key":"B22","unstructured":"Russian Federation National Standard, GOSTR 52379-2005\/ Moscow2005"},{"key":"B23","unstructured":"Content source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)2019"},{"key":"B24","unstructured":"Committee on Human Medicinal Products (CHMP). Guideline on Clinical Evaluation of Vaccines2018"},{"key":"B25","unstructured":"Guidance. Summary of Data to Support the Choice of Influenza Vaccination for Adults in Primary Care2018"},{"key":"B26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/eurpub\/ckz041","article-title":"Adjuvanted influenza vaccine for the Italian elderly in the 2018\/19 season: an updated health technology assessment","volume":"29","author":"de Waure","year":"2019","journal-title":"Eur J Public Health"},{"key":"B27","first-page":"35","article-title":"The results and prospects of researches on the development of artificial vaccines","volume":"6","author":"Khaitov","year":"1982","journal-title":"Immunologiya."},{"key":"B28","first-page":"40","article-title":"Results of the analysis of the new vaccine \u201cGrippol\u00ae plus\u201d immunogenicity","volume":"44","author":"Voitsehovskaya","year":"2009","journal-title":"Epidemiol Vaccin Prev."},{"key":"B29","first-page":"54","article-title":"Vaccine grippol\u00ae neo: results of clinical investigations on safety and reactogenicity (phase II)","volume":"5","author":"Nekrasov","year":"2009","journal-title":"Epidemiol Vaccin Prev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31631\/2073-3046-2016-15-5-63-71","article-title":"Clinical study of safety and efficacy of a polymer-subunit adjuvant influenza vaccine applied in combination with an immune modulator in people aged 60 and over","volume":"15","author":"Romanenko","year":"2016","journal-title":"Epidemiol Vaccin Prev."},{"key":"B31","first-page":"120","article-title":"A study of the clinical safety of pregnant influenza vaccination","volume":"4","author":"Cherdantsev","year":"2011","journal-title":"Med Alman."},{"key":"B32","first-page":"44","article-title":"True and false reactions in pregnant women to introduction of influenza vaccine","volume":"10","author":"Kostinov","year":"2011","journal-title":"Problems of Gynecology, Obstetrics and Perinatology."},{"key":"B33","first-page":"67","article-title":"The efficacy of immunoadjuvant-containing influenza vaccines in pregnancy","volume-title":"Hassan Hemeg and Hani Ozbak","author":"Kostinov","year":"2017"},{"key":"B34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.15789\/2220-7619-2017-2-193-202","article-title":"Immunogenicity of adjuvant influenza vaccine for pregnant women","volume":"7","author":"Kostinov","year":"2017","journal-title":"Russ J Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.26442\/2079-5831_17.4.43-46","article-title":"Obstetric and perinatal outcomes among pregnant women after influenza vaccination and after transferred respiratory infection","volume":"17","author":"Kostinov","year":"2015","journal-title":"Gynecology."},{"key":"B36","first-page":"67","article-title":"Health state of children born from pregnant women vaccinated against influenza","volume":"1","author":"Kostinov","year":"2016","journal-title":"Pediatria."},{"key":"B37","first-page":"112","article-title":"Vaccine prevention of influenza in pregnant woman","volume-title":"Guidelines for doctors","author":"Cherdantsev","year":"2014"},{"key":"B38","first-page":"42","volume-title":"Vaccination against influenza in pregnancy","author":"Zverev","year":"2015"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.17116\/profmed201417613-20","article-title":"Investigation of the efficiency and safety of influenza vaccination in patients with circulatory system diseases","volume":"6","author":"Boytsov","year":"2014","journal-title":"Russian J Prev Med Public Health."},{"key":"B40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.20996\/1819-6446-2016-12-6-703-710","article-title":"Efficiency of influenza vaccination in patients with circulatory system diseases under dispensary observation in outpatient clinics: prospective followup monitoring data","volume":"12","author":"Boytsov","year":"2016","journal-title":"Rational Pharmacotherapy Cardiol."},{"key":"B41","first-page":"50","article-title":"Estimation of Safety and Efficiency of Vaccination From a Flu at Patients with Chronic Obstructive Lung Syndrome","volume":"55","author":"Chebykina","year":"2010","journal-title":"Epidemiol Vacc Prev."},{"key":"B42","first-page":"35","article-title":"Specificities of the formation of post-vaccination immunity to influenza in patients with chronic bronchopulmonary pathologies","volume":"9","author":"Kostinov","year":"2011","journal-title":"Infecti Dis."},{"key":"B43","first-page":"31","article-title":"The effect of active immunization against influenza and pneumococcal infection in children with bronchial asthma on the course of the disease and the microbial spectrum of sputum","volume":"5","author":"Andreeva","year":"2006","journal-title":"Russian J Allergy."},{"key":"B44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5772\/intechopen.77006","article-title":"The impact of adjuvanted and non-adjuvanted influenza vaccines on the innate and adaptive immunity effectors","volume-title":"IntechOpen Book Series. Infectious Diseases, Vol. 1. Influenza. Therapeutics and Challenges","author":"Kostinov","year":"2018"},{"key":"B45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1471-2334-13-343","article-title":"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged \u226518 years","volume":"13","author":"Kieninger","year":"2013","journal-title":"BMC Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1016\/j.vaccine.2013.08.069","article-title":"Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults","volume":"31","author":"P\u00e9pin","year":"2013","journal-title":"Vaccine."},{"key":"B47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/irv.12318","article-title":"Retrospective public health impact of a quadrivalent influenza vaccine in the United States","volume":"9","author":"Cr\u00e9pey","year":"2015","journal-title":"Influenza Other Respir Viruses."},{"key":"B48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/INF.0b013e3181f127be","article-title":"Cross-reactive neutralizing antibody against pandemic (2009)","volume":"30","author":"Hong","year":"2011","journal-title":"H1N1 Influenza a Virus in Intravenous Immunoglobulin Preparations. Pediatr Infect Dis J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciq104","article-title":"Humoral response to the influenza A H1N1\/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients","volume":"52","author":"Manuel","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B50","unstructured":"Pandemrix. Annex IEuropean Medicines Agency, London, United KingdomSummary of Product Characteristics."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2217\/IMT.15.74","article-title":"Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities","volume":"7","author":"Eibl","year":"2015","journal-title":"Immunotherapy."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T04:46:13Z","timestamp":1597812373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2020.01876"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01876","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"article-number":"1876"}}